Reuters logo
in 17 days
BRIEF-India's Lupin gets U.S. FDA nod for generic Ancobon capsules
July 10, 2017 / 7:51 AM / in 17 days

BRIEF-India's Lupin gets U.S. FDA nod for generic Ancobon capsules

1 Min Read

July 10 (Reuters) - Lupin Ltd:

* Says lupin receives fda approval for generic Ancobon capsules

* Says capsules indicated for treatment of serious infections caused by susceptible strains of candida and/or cryptococcus Source text: bit.ly/2tFpTty Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below